Clinical Trials Logo

Clinical Trial Summary

Co-administration of cannabis and tobacco is a common practice, but there is little experimental evidence aimed at understanding the reasons for this prevalence. Some preliminary evidence suggests that tobacco may actually counteract the cognitive-impairing effects of cannabis, and may also increase the subjective ('liking') effects of cannabis, but results are inconclusive. Further, there are no studies into the effects of tobacco on other cannabis-related harms such as driving, or on the ability of tobacco to alter the blood levels of THC, the chemical responsible for the psychoactive properties of cannabis. The purpose of the present study will be to evaluate the effects of tobacco, cannabis or combinations of tobacco and cannabis on driving, cognition, subjective effects and blood THC. Driving will be assessed using a state-of-the-art driving simulator that allows for the safe and objective measurement of the effects of intoxicating substances on driving. Participants will be regular users of cannabis and will be invited to the lab for four counterbalanced test sessions. In these test sessions they will drive the simulator and undergo cognitive tests before and after smoking: 1) cannabis; 2) tobacco; 3) cannabis + tobacco; or 4) placebo. Outcomes will be measured at several time points after smoking the product. Participants will also give blood for determination of levels of THC, and will complete subjective effects questionnaires both before and after smoking the cigarette. This study will be one of the first experimental laboratory studies of the reasons behind co-administration of tobacco and cannabis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05526196
Study type Interventional
Source Centre for Addiction and Mental Health
Contact Patricia Di Ciano
Phone 416-535-8501
Email patricia.diciano@camh.ca
Status Not yet recruiting
Phase N/A
Start date August 1, 2024
Completion date March 1, 2027

See also
  Status Clinical Trial Phase
Completed NCT00648206 - Testing Alcohol Only Samples for Drugs and Drugs Only Samples for Alcohol N/A
Completed NCT04230460 - Cannabis Impairment Detection Application (CIDA) N/A
Completed NCT03506880 - Project MADD - NIH Underage DUI and Ride N/A
Completed NCT05028413 - Evaluating Perceived Fitness to Drive While Intoxicated N/A
Completed NCT02071836 - A Web Application to Reduce Heavy Drinking in First-time DWI Offenders N/A
Completed NCT00650130 - Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines N/A
Recruiting NCT04450966 - Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care N/A
Completed NCT04247191 - Parent Intervention to Reduce College Student Drinking and Consequences N/A
Completed NCT04970342 - Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim Phase 1
Completed NCT03335735 - Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving N/A
Active, not recruiting NCT01590277 - Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans Phase 1
Withdrawn NCT05273658 - Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests Phase 1/Phase 2
Completed NCT05437081 - A Family-Based Alcohol Preventive Intervention for Latino Emerging Adults N/A
Completed NCT03503396 - Alcohol Impaired Driving in the Natural Environment N/A